Aqueous phase reforming for biorefinery stream valorization

L'abstract è presente nell'allegato / the abstract is in the attachmen

Hydrothermal liquefaction of food waste: optimization and kinetic modelling

Please click Additional Files below to see the full abstrac

Towards the sustainable hydrogen production by catalytic conversion of C-laden biorefinery aqueous streams

An extensive screening of representative molecules of a post-hydrothermal process side stream has been performed with the aim of producing a gas mixture rich in hydrogen by catalytic aqueous phase reforming. The survey enlightens possible routes of valorisation of these by-products, scarcely investigated with other processes so far. The influence of reaction temperature was studied in the 230–270 °C range, looking at both the composition of the gas phase and the characterization of the liquid products. Indeed, the information coming from the condensed phase may provide relevant insights on the components that are not easily reformed, and that should be studied to improve the performance of the process. Binary and ternary mixtures of four selected compounds were tested to investigate synergistic and inhibiting effects, going towards the direction of a real biorefinery stream. The spent alumina-supported catalyst was characterized, outlining possible deactivation mechanisms of the catalytic system, and reused in two successive tests

Aqueous phase reforming of lignin-rich hydrothermal liquefaction by-products: a study on catalyst deactivation

The water fraction derived from the hydrothermal liquefaction of a lignin-rich feedstock was subjected to aqueous phase reforming to produce hydrogen. Deactivation of the catalyst was observed, and it was ascribed to fouling phenomena caused by phenolic oligomers. Simple aromatics like guaiacol and phenol, as well as in-organics, were proved not to be the cause of the deactivation thanks to the use of a multi-component synthetic mixture. The influence of using activated carbon as a pretreatment was studied, leading to a strong improvement of the performance when it was carried out at high temperature. The extent of deactivation was assessed using aqueous phase reforming of glycolic acid as a model reaction test. The results were found to be correlated with the surface area of the catalyst. A thermal regeneration in inert conditions was evaluated as a mode of catalyst regeneration. While the textural properties were partially recovered, the performance of the catalyst only slightly improved. A spectroscopic analysis of the solids in the aqueous solution was carried out, highlighting the structural similarities between their nature and the lignin residue. The results obtained in this study helped to enlarge the knowledge on the aqueous phase reforming of real complex mixtures, looking at indicators of paramount importance for a possible industrial application such as the stability of the catalyst

Transcriptome-wide expression profiling in skin fibroblasts of patients with joint hypermobility syndrome/ehlers-danlos syndrome hypermobility type

Joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type (JHS/EDS-HT), is likely the most common systemic heritable connective tissue disorder, and is mostly recognized by generalized joint hypermobility, joint instability complications, minor skin changes and a wide range of satellite features. JHS/EDS-HT is considered an autosomal dominant trait but is still without a defined molecular basis. The absence of (a) causative gene(s) for JHS/EDS-HT is likely attributable to marked genetic heterogeneity and/or interaction of multiple loci. In order to help in deciphering such a complex molecular background, we carried out a comprehensive immunofluorescence analysis and gene expression profiling in cultured skin fibroblasts from five women affected with JHS/EDS-HT. Protein study revealed disarray of several matrix structural components such as fibrillins, tenascins, elastin, collagens, fibronectin, and their integrin receptors. Transcriptome analysis indicated perturbation of different signaling cascades that are required for homeostatic regulation either during development or in adult tissues as well as altered expression of several genes involved in maintenance of extracellular matrix architecture and homeostasis (e.g., SPON2, TGM2, MMP16, GPC4, SULF1), cell-cell adhesion (e.g., CDH2, CHD10, PCDH9, CLDN11, FLG, DSP), immune/inflammatory/pain responses (e.g., CFD, AQP9, COLEC12, KCNQ5, PRLR), and essential for redox balance (e.g., ADH1C, AKR1C2, AKR1C3, MAOB, GSTM5). Our findings provide a picture of the gene expression profile and dysregulated pathways in JHS/EDS-HT skin fibroblasts that correlate well with the systemic phenotype of the patients

Conceptual design and techno-economic assessment of coupled hydrothermal liquefaction and aqueous phase reforming of lignocellulosic residues

Hydrothermal liquefaction is a promising technology for producing renewable advanced biofuels. However, some weaknesses could undermine its large-scale application, such as the significant carbon loss in the aqueous phase (AP) and the necessity of biocrude upgrading. In order to deal with these challenges, in this work the techno-economic feasibility of coupling hydrothermal liquefaction (HTL) with aqueous phase reforming (APR) was evaluated. APR is a catalytic process able to convert water-dissolved oxygenates into a hydrogen-rich gas that can be used for biocrude upgrading. Two cases were proposed, based on different lignocellulosic feedstocks: corn stover (CS) and lignin-rich stream (LRS) from cellulosic ethanol production. HTL-APR plants operating with the same mass flow (3.6 t/h) at 10 wt% solid loading were herein evaluated, resulting in an input size of 20 MW (LRS) and 16.5 MW (CS). Based on experimental and literature data, the mass and energy balances were per- formed; subsequently, the main equipment was designed; finally, the capital and operating costs were evaluated. The analysis showed that the minimum selling prices for the biofuel (0% internal rate of return) were 1.23 (LRS) and 1.27 €/kg (CS). The heat exchangers accounted for most of the fixed capital investment, while electricity and feedstock had the highest impact on the operating costs. The implementation of APR was particularly profitable with CS, as it produced 107% of the hydrogen required for biocrude upgrading. In this case, APR was able to significantly reduce the H2 production cost (1.5 €/kg) making it a competitive technology compared to con- ventional electrolysis

GLUT10-Lacking in Arterial Tortuosity Syndrome-Is Localized to the Endoplasmic Reticulum of Human Fibroblasts.

GLUT10 belongs to a family of transporters that catalyze the uptake of sugars/polyols by facilitated diffusion. Loss-of-function mutations in the SLC2A10 gene encoding GLUT10 are responsible for arterial tortuosity syndrome (ATS). Since subcellular distribution of the transporter is dubious, we aimed to clarify the localization of GLUT10. In silico GLUT10 localization prediction suggested its presence in the endoplasmic reticulum (ER). Immunoblotting showed the presence of GLUT10 protein in the microsomal, but not in mitochondrial fractions of human fibroblasts and liver tissue. An even cytosolic distribution with an intense perinuclear decoration of GLUT10 was demonstrated by immunofluorescence in human fibroblasts, whilst mitochondrial markers revealed a fully different decoration pattern. GLUT10 decoration was fully absent in fibroblasts from three ATS patients. Expression of exogenous, tagged GLUT10 in fibroblasts from an ATS patient revealed a strict co-localization with the ER marker protein disulfide isomerase (PDI). The results demonstrate that GLUT10 is present in the ER

Acute Delta Hepatitis in Italy spanning three decades (1991–2019): Evidence for the effectiveness of the hepatitis B vaccination campaign

Updated incidence data of acute Delta virus hepatitis (HDV) are lacking worldwide. Our aim was to evaluate incidence of and risk factors for acute HDV in Italy after the introduction of the compulsory vaccination against hepatitis B virus (HBV) in 1991. Data were obtained from the National Surveillance System of acute viral hepatitis (SEIEVA). Independent predictors of HDV were assessed by logistic-regression analysis. The incidence of acute HDV per 1-million population declined from 3.2 cases in 1987 to 0.04 in 2019, parallel to that of acute HBV per 100,000 from 10.0 to 0.39 cases during the same period. The median age of cases increased from 27 years in the decade 1991-1999 to 44 years in the decade 2010-2019 (p < .001). Over the same period, the male/female ratio decreased from 3.8 to 2.1, the proportion of coinfections increased from 55% to 75% (p = .003) and that of HBsAg positive acute hepatitis tested for by IgM anti-HDV linearly decreased from 50.1% to 34.1% (p < .001). People born abroad accounted for 24.6% of cases in 2004-2010 and 32.1% in 2011-2019. In the period 2010-2019, risky sexual behaviour (O.R. 4.2; 95%CI: 1.4-12.8) was the sole independent predictor of acute HDV; conversely intravenous drug use was no longer associated (O.R. 1.25; 95%CI: 0.15-10.22) with this. In conclusion, HBV vaccination was an effective measure to control acute HDV. Intravenous drug use is no longer an efficient mode of HDV spread. Testing for IgM-anti HDV is a grey area requiring alert. Acute HDV in foreigners should be monitored in the years to come

Molecular insights in the pathogenesis of classical Ehlers-Danlos syndrome from transcriptome-wide expression profiling of patients' skin fibroblasts

Classical Ehlers-Danlos syndrome (cEDS) is a dominant inherited connective tissue disorder mainly caused by mutations in the COL5A1 and COL5A2 genes encoding type V collagen (COLLV), which is a fibrillar COLL widely distributed in a variety of connective tissues. cEDS patients suffer from skin hyperextensibility, abnormal wound healing/atrophic scars, and joint hypermobility. Most of the causative variants result in a non-functional COL5A1 allele and COLLV haploinsufficiency, whilst COL5A2 mutations affect its structural integrity. To shed light into disease mechanisms involved in cEDS, we performed gene expression profiling in skin fibroblasts from four patients harboring haploinsufficient and structural mutations in both disease genes. Transcriptome profiling revealed significant changes in the expression levels of different extracellular matrix (ECM)-related genes, such as SPP1, POSTN, EDIL3, IGFBP2, and C3, which encode both matricellular and soluble proteins that are mainly involved in cell proliferation and migration, and cutaneous wound healing. These gene expression changes are consistent with our previous protein findings on in vitro fibroblasts from other cEDS patients, which exhibited reduced migration and poor wound repair owing to COLLV disorganization, altered deposition of fibronectin into ECM, and an abnormal integrin pattern. Microarray analysis also indicated the decreased expression of DNAJB7, VIPAS39, CCPG1, ATG10, SVIP, which encode molecular chaperones facilitating protein folding, enzymes regulating post-Golgi COLLs processing, and proteins acting as cargo receptors required for endoplasmic reticulum (ER) proteostasis and implicated in the autophagy process. Patients' cells also showed altered mRNA levels of many cell cycle regulating genes including CCNE2, KIF4A, MKI67, DTL, and DDIAS. Protein studies showed that aberrant COLLV expression causes the disassembly of itself and many structural ECM constituents including COLLI, COLLIII, fibronectin, and fibrillins. Our findings provide the first molecular evidence of significant gene expression changes in cEDS skin fibroblasts highlighting that defective ECM remodeling, ER homeostasis and autophagy might play a role in the pathogenesis of this connective tissue disorder